Peter Caravan
Peter Caravan
Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging (i3), MGH, Harvard
Verified email at nmr.mgh.harvard.edu
Title
Cited by
Cited by
Year
Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications
P Caravan, JJ Ellison, TJ McMurry, RB Lauffer
Chemical reviews 99 (9), 2293-2352, 1999
48461999
The chemistry of contrast agents in medical magnetic resonance imaging
AS Merbach, L Helm, E Toth
John Wiley & Sons, 2013
14682013
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
P Caravan
Chemical Society Reviews 35 (6), 512-523, 2006
14422006
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates
P Caravan, NJ Cloutier, MT Greenfield, SA McDermid, SU Dunham, ...
Journal of the American Chemical Society 124 (12), 3152-3162, 2002
4902002
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium‐ and manganese‐based T1 contrast agents
P Caravan, CT Farrar, L Frullano, R Uppal
Contrast media & molecular imaging 4 (2), 89-100, 2009
4722009
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
S Aime, P Caravan
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
4642009
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action
P Caravan
Accounts of chemical research 42 (7), 851-862, 2009
3952009
Chemistry of MRI contrast agents: current challenges and new frontiers
J Wahsner, EM Gale, A Rodríguez-Rodríguez, P Caravan
Chemical reviews 119 (2), 957-1057, 2018
3672018
Primer on gadolinium chemistry
AD Sherry, P Caravan, RE Lenkinski
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
3542009
Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent
C Orvig, P Caravan, L Gelmini, N Glover, FG Herring, H Li, JH McNeill, ...
Journal of the American Chemical Society 117 (51), 12759-12770, 1995
3041995
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
2342014
Collagen‐targeted MRI contrast agent for molecular imaging of fibrosis
P Caravan, B Das, S Dumas, FH Epstein, PA Helm, V Jacques, S Koerner, ...
Angewandte Chemie International Edition 46 (43), 8171-8173, 2007
2252007
EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus
K Overoye-Chan, S Koerner, RJ Looby, AF Kolodziej, SG Zech, Q Deng, ...
Journal of the American Chemical Society 130 (18), 6025-6039, 2008
2052008
Clinical magnetic resonance imaging
RR Edelman
Saunders Elsevier, 2006
2042006
Enzyme‐Activated Gd3+ Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor‐Induced Magnetization Enhancement
AL Nivorozhkin, AF Kolodziej, P Caravan, MT Greenfield, RB Lauffer, ...
Angewandte Chemie 113 (15), 2987-2990, 2001
1692001
A manganese alternative to gadolinium for MRI contrast
EM Gale, IP Atanasova, F Blasi, I Ay, P Caravan
Journal of the American Chemical Society 137 (49), 15548-15557, 2015
1622015
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility
J Vymazal, E Spuentrup, G Cardenas-Molina, AJ Wiethoff, MG Hartmann, ...
Investigative radiology 44 (11), 697-704, 2009
1592009
Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent1
PA Helm, P Caravan, BA French, V Jacques, L Shen, Y Xu, RJ Beyers, ...
Radiology 247 (3), 788-796, 2008
1572008
Molecular and cellular MR imaging
MMJ Modo, JWM Bulte
CRC Press, 2007
1552007
Bimodal MR–PET agent for quantitative pH imaging
L Frullano, C Catana, T Benner, AD Sherry, P Caravan
Angewandte Chemie International Edition 49 (13), 2382-2384, 2010
1542010
The system can't perform the operation now. Try again later.
Articles 1–20